by Surgical Synergy

Innovation in Keyhole Surgery

£498THOUSANDInvested to date

£1.25MILLION

Fundraise 2016/17

15.0%EQUITYShareholding

EIS APPROVED

Tax efficiency

3x PATENTS

2x FUTURE

Products Planned

$45 BILLION

Market by 2020

Founder & Inventor One of the world’s pioneering Endoscopic spine surgeons.

Martin Knight Chairman &

Chief Medical Officer

Our award winning design partner

2000+SURGEONS

PREFORM HIS TECHNIQUES

25+PUBLISHED

JOURNAL CREDITS

32+PUBLISHED

NON JOURNAL CREDITS

3xIP

PATENTS

Martin Knight Chairman &

Chief Medical Officer

Ieuan Griffiths CEO

Potential Distributors

Roger JohnCTO

TEAM

Challenging Times for Healthcare

“New medical devices are attempting to provide surgeons with high-efficiency multifunctional devices that cut costs over time.”

#Healthcare Funding Crisis

“This new emphasis on managing and decreasing postoperative patient recovery times could allow laparoscopy to tap into a significantly larger patient pool”.

www.meddeviceonline.com

Endoscopy Looking inside the body to examine the interior of a hollow organ or cavity

Laproscopy Keyhole surgery performed through small incisions

Instruments repeatedly changed between access portals

Endoscope (Camera) needs to change position

Single view-point

Blunt or failing instruments

Endoscope is rigid.

Assistant provides the wrong instrument

Challenging ops need more incisions

Abdominal & Pelvic Surgery

A Simple Solution

CAMERA & LIGHT

6x Tools

Improved Vision - Disposable Tips - Novel Cassette - Always Sharpe

3x Patents2x to follow

Quicker & Less Invasive Operations

Medusascope™

Reduces incision Better patient outcomesFrees up hospital beds

Reduces operation timesFewer infections

Reduce costs

Medusascope™

Close up view 2nd angle of vision

Reduces operating risk30% quicker instrument change

Less surgeon fatigueTools always sharp

Medusascope™

Fewer incisionsImproved patient satisfaction

Better health outcomesFewer port-site complications

Less post-operative pain Faster recovery

PATIENTSSURGEONSHOSPITAL

FUNDED FUNDING

FUNDING

TODAY

2015Q3

2016Q4

12+ Months

18 Months

£498kFUNDING

£1.25MILLION

£4MILLION

PHASE ONEProof of Concept / Working Prototype

Basic working prototype confirming technical feasibility. Refinement of prototype for initial

testing completed Q4 2016.

PHASE TWOOptimise DesignMarket TestingClinical Testing

Pre-Production SpecificationCamera Software DevelopmentIntegration to theatre systemsApplication for accreditation

PHASE THREEDevelopment of Flexible Version

Small Bore Version from 6.3mm to 2.8mm

Accreditation FDA USA & CE for Europe

£86kFOUNDER

£300kINVESTORS

£112kGRANT

PHASE THREE PHASE TWO PHASE ONE

£212THOUSAND

sales

2017 2018 2019 2020 2021 2022

£1.7mEBITDA

£9mEBITDA

£20mEBITDA

£1.8MILLION

sales

£9.1MILLION

sales

£28MILLION

sales

£62MILLION

sales

£300MILLION

EXIT*

* Recent exits show 15x EBITDA as an average. Appendix highlights recent acquisitions and exits.

£1.25MILLION

£4MILLION

FUNDING ROUND FUNDING ROUND

Use of Funds & Future Goals

Development of Flexible Version Small Bore Version

from 6.3mm to 2.8mmAccreditation FDA USA &

CE for Europe

Optimise DesignMarket TestingClinical Testing

Pre-Production SpecificationCamera Software DevelopmentIntegration to theatre systemsApplication for accreditation

ASIA-PacificFastest Growing Market

8.6%CAGR to 2020

32%USA

33%Rest of the

World

25%EUROPE

10%JAPAN

13%of all Obese People Live in US

Fuelling the rise in Bariatrics Keyhole Surgery

Global Laparoscopy Devices Market (Abdominal cavity surgery only)

2025

33.8%Global Laproscopic

Instruments Market 2016

39%US Laproscopic

Device Market 2015

$7.9BILLION

2014

$16.3BILLIONWhy is it Growing?

Rise in 60+ Age Group

Increase in Obesity

Advances in Technology

Lower cost of Key Hole Surgery

Increased Awareness

15MILLION

Key Hole Surgeries Performed Globally

7.5% CAGR2016 to 2025

TOP 5 COMPETITORS

Ethicon, a medical device company of Johnson & Johnson commands 39% of the US market.

by Surgical Synergy

THANK YOU